The Feedback Phase of Type I Interferon Induction in Dendritic Cells Requires Interferon Regulatory Factor 8  by Tailor, Prafullakumar et al.
Immunity
ArticleThe Feedback Phase of Type I Interferon Induction
in Dendritic Cells Requires
Interferon Regulatory Factor 8
Prafullakumar Tailor,1 Tomohiko Tamura,1,3 Hee Jeong Kong,1,4 Toru Kubota,1,5 Mayumi Kubota,1,5
Paola Borghi,2 Lucia Gabriele,2 and Keiko Ozato1,*
1Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development,
National Institutes of Health, Bethesda, MD 20892, USA
2Laboratory of Virology, Istituto Superiore di Sanita`, Rome 00161, Italy
3Present address: Osaka City University Graduate School of Medicine, Osaka 545-8586, Japan.
4Present address: Biotechnology Research Institute, National Fisheries Research and Development Institute, Busan 619-705,
Republic of Korea.
5Present address: National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
*Correspondence: ozatok@nih.gov
DOI 10.1016/j.immuni.2007.06.009SUMMARY
Dendritic cells (DCs) produce type I interferons
(IFNs) in greater amounts than other cells, but
the mechanisms remain elusive. Here we stud-
ied the role of a transcription factor, IRF8, in
DC induction of type I IFNs. Upon newcastle
disease virus (NDV) infection, bone marrow-
derived plasmacytoid and conventional DCs
induced IFN transcripts, exhibiting two-phase
kinetics. The second, amplifying phase repre-
sented an IFN feedback response that ac-
counted for much of IFN protein production. In-
duction of second phase transcription required
IRF8.Mouse cytomegalovirus (MCMV) and Toll-
like receptor-mediated IFN induction in DCs
also required IRF8. Chromatin immunoprecipi-
tation analysis showed that IRF7, IRF8, and
RNA polymerase II were recruited to the IFN
promoters upon stimulation. Moreover, sus-
tained RNA polymerase II recruitment to the
promoters critically depended on IRF8. To-
gether, these data indicate that IRF8 magnifies
the second phase of IFN transcription in DCs
by prolonging binding of basic transcription
machinery to the IFN promoters, thereby play-
ing a role in innate immunity.
INTRODUCTION
Type I interferons (IFNs) are produced immediately after
pathogen infection, profoundly influencing the nature of
innate and adaptive immunity (Biron, 2001). Although
many types of cells produce type I IFNs, dendritic cells
(DCs) are the highest IFN producers (Asselin-Paturel
et al., 2001; Siegal et al., 1999), accounting for the early
establishment of innate immunity (Asselin-Paturel and228 Immunity 27, 228–239, August 2007 ª2007 Elsevier Inc.Trinchieri, 2005; Banchereau et al., 2004). Type I IFN en-
coding genes belong to a multigene family consisting of
more than 10 Ifna genes and a single Ifnb gene, all clus-
tered in a 500 kb long region in chromosome 4 in the
mouse (Pestka et al., 2004). IFN induction is mediated
through Toll-like receptor (TLR) signaling, which simulates
sequential activation of adaptors and kinases of the inter-
leukin (IL)-1 receptor-associated kinase (IRAK), inhibitor of
kappaB kinase (IKK), and Tnf receptor-associated factor
(TRAF) families, ultimately leading to the activation of tran-
scription factors, interferon regulatory factor 3 (IRF3), in-
terferon regulatory factor 7 (IRF7), and nuclear factor of
kappa light chain gene enhancer in B cells (NF-kB) (Honda
and Taniguchi, 2006; Kawai and Akira, 2006). Besides TLR
signaling, activation of RNA helicase pathways such as
retinoic acid-inducible gene I (RIG-I) leads to activation
of IRF3 and type I IFN induction (Honda and Taniguchi,
2006; Yoneyama et al., 2005).
Mechanisms underlying type I IFN gene induction have
been extensively studied in non-DCs, including fibroblasts
(Civas et al., 2002; Marie et al., 1998; Sato et al., 2000).
These studies showed that IFN production involves initial
induction of Ifnb and Ifna4 transcripts that aremediated by
IRF3 and IRF7. These IRFs are phosphorylated, dimer-
ized, and translocated into the nucleus to activate the
two IFN genes (Sharma et al., 2003). This initial event
then leads to the next stage of transcription where addi-
tional Ifna encoding genes and Irf7 are induced in an
IFN-dependent manner (Marie et al.,1998; Tailor et al.,
2006). A recent study indicates that IRF7, not IRF3, is
essential for the initial IFN induction both in DCs and
non-DCs (Honda et al., 2005b).
DCs are a heterogeneous population of cells with di-
verse functions. Although it was previously thought that
plasmacytoid DCs (pDCs) are responsible for much of
type I IFN production, more recent studies showed that
conventional DCs (cDCs) also produce considerable
amounts of type I IFNs (Diebold et al., 2003; Kato et al.,
2005). pDCs seem to have several distinct characteris-
tics that might be relevant to high IFN production. For
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Role of IRF8 in Type I IFN Induction in DCsexample, the TLR complexes containing MyD88 and IRF7
are retained in pDCs longer than in other cells (Honda
et al., 2005a). In addition, pDCs express IRF7 at high
amounts, possibly enabling enhanced IFN gene activation
(Dai et al., 2004). Furthermore, the RNA helicase-RIG I
pathway appears dispensable in pDCs (Kato et al., 2005).
Despite intense interest, molecular mechanisms by
which pDCs and in some cases cDCs express high
amounts of type I IFNs have remained poorly understood.
Although several reports indicated an IFN feedback as an
important mechanism of IFN production in DCs, evidence
is inconsistent, making it uncertain as to the significance
of the feedback loop (Gautier et al., 2005; Honda et al.,
2005b; Kerkmann et al., 2003). Another unsolved question
is the role of IRF8 in DC induction of type I IFN genes. IRF8
is an immune system-specific member of the IRF family
(Levi et al., 2002; Tailor et al., 2006; Tamura and Ozato,
2002). It is a nuclear protein expressed at high amounts
in pDC and other DC subtypes (Tamura et al., 2005a).
We previously showed that Irf8/ DCs produced little
type I IFNs and that reintroduction of IRF8 rescued type
I IFN induction in Irf8/ DCs (Schiavoni et al., 2002;
Tamura et al., 2005a; Tsujimura et al., 2003b). In addition,
IRF8 is essential for the development of DC subsets, par-
ticularly pDCs andCD8a+ DCs, although anothermember,
IRF4, also contributes to pDC development, albeit to a mi-
nor extent (Aliberti et al., 2003; Schiavoni et al., 2002;
Tamura et al., 2005a; Tsujimura et al., 2003a, 2003b). Be-
cause of its prominent role in DC development, the contri-
bution of IRF8 to IFN induction in differentiated DCs has
not been fully elucidated so far.
The present study reveals two notable aspects of IFN
transcription that are different between DCs and other
cell types. First, many Ifna subtypes are induced immedi-
ately in the first phase prior to the initiation of IFN feedback
response. IRF8 is required for the second, amplifying
phase of IFN induction both in pDCs and cDCs, although
IRF8 is not required for the activation of IRF3 or IRF7. Our
results indicate that the role of IRF8 is to help prolong the
recruitment of basal transcription machinery to the IFN
promoters, a role not shared by IRF7 or IRF3, which sup-
ports characteristically high IFN transcription in DCs.
RESULTS
Two-Phase Kinetics of Type I IFN Induction in DCs:
The Absence of the Second Phase Peak
in Irf8/ DCs
To study the mechanism of type I IFN gene induction in
DCs, bone marrow-derived Irf8+/+ and Irf8/ DCs gener-
ated in the presence of Flt3L were exposed to newcastle
disease virus (NDV) for 1 hr. Cells were washed and then
incubated in freshmedia for up to 24 hr. Ifna transcripts in-
duced after viral exposure were measured by quantitative
(q) RT-PCR with a primer set that detected all Ifna sub-
types (Figure 1A). The transcript induction in Irf8+/+ DCs
followed two-phase kinetics, exhibiting two peaks. The
first relatively small peak was seen at 1 hr, followed by
the greater second peak at 7 hr. Strikingly, Irf8/ DCsdid not elicit the second peak, although they elicited the
first peak similar to that in Irf8+/+ cells in terms of timing
and transcript expression. In Figure 1B, the amount of
IFNA proteins secreted from Irf8+/+ DCs rose sharply dur-
ing initial 11 hr and plateaued thereafter. In contrast, IFNA
produced in Irf8/ DCs remained near background
expression, in line with previous reports (Schiavoni et al.,
2002; Tamura et al., 2005a; Tsujimura et al., 2003b). Given
that IFN protein production was virtually absent in Irf8/
DCs, despite the presence of the first transcript peak, it
is likely that much of IFN protein production in DCs is
accounted for by the second phase of IFN transcript ex-
pression. In Figure 1C, Ifnb transcript expression dis-
played similar two-phase kinetics in Irf8+/+ DCs. Again,
the second peak was completely missing in Irf8/ DCs,
although the first peak in Irf8/ DCs was higher than
that in Irf8+/+ DCs.
The two-phase kinetics observed above is reminiscent
of two-step IFN induction described for non-DCs (Civas
et al., 2002; Marie et al., 1998; Sato et al., 2000). In non-
DCs, Ifnb and Ifna4 are the first subtypes expressed in
the early stage, and other, non-a4 Ifna subtypes are ex-
pressed in the second stage. To assess whether Ifna sub-
types were induced in a similar, hierarchical order in DCs,
expression of non-a4 Ifna transcripts was examined.
Semiquantitative RT-PCR rather than qRT-PCR was em-
ployed in these experiments, because selection of primers
that could detect individual non-a4 Ifna transcripts in qRT-
PCR was not practical. As seen in Figure 1D, non-a4 Ifna
transcripts were induced at 1 hr along with induction of
Ifnb and Ifna4 both in Irf8+/+ and Irf8/ DCs. In Irf8+/+
DCs, the expression of non-a4 Ifna mRNA transcripts
markedly increased at 7 hr, along with an increase in
Ifna4 and Ifnb mRNAs. In Irf8/ DCs, however, neither
non-a4 Ifna, Ifna4, nor Ifnb transcripts were detected at
7 hr and thereafter. These data indicate that contrary to
non-DCs, multiple Ifna subtypes are induced in the first
phase in DCs, and their expression is enhanced in the sec-
ond phase. Determination of 25 Ifna transcript sequences
expressed at 1 hr in DCs confirmed the abundant
presence of non-a4 Ifna IFN species in the first phase
(Table S1 in the Supplemental Data available online).
The Role of IRF8 in Type I IFN Expression in cDCs
We noted that 20%–30% of Irf8+/+ DCs were pDCs car-
rying B220, Siglec-H, and Ly49Q, whereas cells with these
markers were virtually nonexistent in Irf8/ DCs (Fig-
ure S1). Because the failure of Irf8/ DCs to elicit the sec-
ond IFN peak may be attributed to the absence of pDCs in
the culture, we tested whether IFNs were induced in cDCs
after NDV stimulation. MACS fractionation of total DCs
from Irf8+/+ mice yielded a clean cDC population in which
B220+ pDC were 0.1%. The other, remaining population
was enriched with pDCs (70% B220+) (Figure S2). Ifna
transcripts were induced both in cDCs and pDC-enriched
populations, both showing two peaks, similar to those
in total DCs. Similarly, Ifnb transcripts were expressed in
the both cDCs and pDC-enriched cells, generating again
two peaks resembling those in total DCs. These resultsImmunity 27, 228–239, August 2007 ª2007 Elsevier Inc. 229
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Role of IRF8 in Type I IFN Induction in DCsFigure 1. Two-Phase Kinetics of Type I IFN Transcript Induction in DCs
(A) DCs from Irf8+/+ and Irf8/mice were infected with NDV for 1 hr and washed, and IfnamRNA expression was measured at indicate times (hr) by
qRT-PCR with pan-Ifna primers. Values represent the average of three determinations ± SD. Seven separate experiments yielded similar data.
(B) IFNA protein production in above cells was measured by ELISA. Data are representative of three experiments.
(C) Ifnb mRNA expression in above cells was measured with Ifnb primers as in (A).
(D) Semiquantitative RT-PCRwas performed for Ifna4 and non-a4 Ifna transcripts in Irf8+/+ and Irf8/ cells at indicated times after NDV infection as in
(A). Data are representative of two experiments.show that type I IFN genes are induced both in cDC and
pDC after NDV stimulation and that the absence of the
second peak in Irf8/ DCs was not due the absence
of pDCs but rather was due to the absence of IFN
mRNA expression.
Because Flt3L and GM-CSF promote development of
different DC subsets (Gilliet et al., 2002; Tamura et al.,
2005a), IFN induction was also studied in GM-CSF-
derived DCs (Figure S3). After NDV stimulation, Irf8+/+
DCs from GM-CSF culture expressed much lower Ifna
transcripts and proteins than those from the Flt3L culture.
More importantly, IFN induction in Irf8/ DCs from GM-
CSF culture were at a background amount (Figure S3).
These results are in agreement with the previous observa-
tions that Flt3L, but not GM-CSF, supports development
of IFN-producing cells (Tamura et al., 2005b).
It was important to test whether the requirement of IRF8
is limited to the NDV system or whether this requirement is
a more general aspect of DC IFN induction. To address
this question, we infected Irf8+/+ and Irf8/ DCs with
the murine cytomegalovirus (MCMV). Results in Figure 2A
show that whereas Irf8+/+ DCs induced Ifna transcripts at
high amounts that peaked at 7 hr, Irf8/ DCs expressed
virtually no IFN transcripts. Ifnb expression exhibited es-230 Immunity 27, 228–239, August 2007 ª2007 Elsevier Inc.sentially the same pattern, where the transcripts were
almost undetectable in Irf8/ DCs. Consequently, little
IFN proteins were produced in Irf8/ cells in contrast to
Irf8+/+ cells that yielded a ng/ml order of IFNs. Vesicular
stomatitis virus (VSV), another virus we tested, led to
much lower expression of IFN transcripts than NDV and
MCMV. Nevertheless, Irf8+/+ DCs expressed measurable
amounts of IFN transcripts, whereas Irf8/ DCs induced
Ifna transcripts at amounts barely above detection (data
not shown). In Figures 2B and 2C, ligands for TLR 3, 7,
and 9 (poly IC, R848, and CpG, respectively) were tested
for IFN induction. These ligands constitute major compo-
nents of RNA and DNA viruses. In Irf8+/+ DCs, CpG DNA
led to the highest induction of both Ifna and Ifnb tran-
scripts and proteins, although other ligands also stimu-
lated IFN transcript induction. In contrast, essentially no
IFN transcripts were expressed in Irf8/ DCs in response
to these TLR ligands. These results show that the defect in
expressing type I IFN in Irf8/ DCs is not a specialized
feature limited to certain stimuli, but it represents a funda-
mental, mechanistic deficit of the Irf8/ DCs. Unlike what
was observed with the NDV stimulation, the above stimuli
elicited a single major IFN transcripts peak and did not
display two clear peaks. It is likely that these stimuli
Immunity
Role of IRF8 in Type I IFN Induction in DCsFigure 2. Absence of IFN Induction in Irf8/ DCs after MCMV Infection and TLR Signaling
(A) DCs were stimulated with MCMV for 1 hr, and induction of Ifna (circle) and Ifnb (square) transcripts and IFNA protein production was measured as
in Figure 1. Values represent the average of thee assays ± SD.
(B and C) DCs were stimulated with indicated TLR ligands, and Ifna (circle) and Ifnb (square) transcripts and proteins were detected as above. The
ligands were present for the entire incubation time. Abbreviation: UD, IFN production was undetectable in Irf8/ DCs. Values in (B) represent the
average of three assays ± SD, and all data were reproduced in two separate assays.generated two peaks in a shorter, overlapping interval, in-
dicating that IFN induction kinetics may differ depending
on types of stimuli.
The Second Peak Represents an IFN
Feedback Response
We surmised that the second peak elicited by NDVwas an
equivalent of the IFN feedback loop described for non-
DCs. To ascertain whether this idea holds true, we tested
IFN transcript induction in DCs from Ifnar1/ mice that
would not generate the feedback loop because of the
lack of type I IFN receptor. DCs generated from Ifnar1+/+
and Ifnar1/ mice, both in the BALB/c background, con-
tained similar percentages of pDCs (Figure 3A). InFigure 3B, although Ifnar1+/+ DCs showed a typical two-
phase IFN mRNA induction upon NDV addition, Ifnar1/
DCs produced no detectable second peak. The first
peak in Ifnar1/ DCs, although observed reproducibly,
was lower than in Ifnar1+/+ DCs, possibly because of prior
IFN priming in Ifnar1+/+ DCs. These data indicate that the
second IFN peak, missing in Irf8/ DCs, is accounted
for by an IFN feedback response, which provides a major
mechanism of enhanced IFN induction in DCs.
The above results raised the possibility that Irf8/ DCs
were deficient in responding to the IFN feedback signal.
To test this possibility, we examined expression of several
classical IFN-responsive genes (Figure 3C). Upon IFNA
addition, 20-50 oligo (A) synthetase (2-5OAS), interferonImmunity 27, 228–239, August 2007 ª2007 Elsevier Inc. 231
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Role of IRF8 in Type I IFN Induction in DCsFigure 3. The Absence of the Second Peak in Ifnar1/ DCs after NDV Infection
(A) Flow cytometry detection of pDCs in Ifnar1+/+ and Ifnar1/ DCs. B220+ and CD11b+ (MacI) cells are boxed in each panel.
(B) Ifna transcripts in above cells were measured as in Figure 1A.
(C) cDCs and pDC-enriched cells from Irf8+/+ mice and DCs from Irf8/ or Ifnar1/mice were stimulated with 500 U/ml of IFNA, and expression of
indicated genes was monitored by qRT-PCR at indicated times. All data in Figure 3 were reproduced in at least two experiments.induced transmembrane protein 3 (IFITM3), and IRF7
were expressed in Irf8/ DCs along with Irf8+/+ pDCs
and Irf8+/+ cDCs, indicating that Irf8/ DCs respond to
IFN signals. Only Ifnar1/ DCs failed to express these
genes. Supporting the idea that Irf8/ DCs are capable
of responding to the IFN feedback signal generated by
viral stimulation, the above genes were also induced after
NDV infection in both Irf8+/+ and Irf8/ DCs (Figure S4).
To further delineate defects in Irf8/ DCs, we asked
whether IRF3 and IRF7 are activated in Irf8/ DCs. To
this end, nuclear translocation of the two proteins was ex-
amined, because it represented an endpoint event of TLR
signaling, initiating IFN gene transcription. For IRF7, we
analyzed DCs expressing IRF7 cDNA fused to the green
fluorescent protein (GFP), because available antibodies
were not suitable for immunostaining of endogenous
IRF7. As seen in Figure 4A, IRF7-GFP was distributed
mostly in the cytoplasm prior to infection. One hour after
stimulation, intense fluorescent signals were observed in
the nucleus (except for nucleoli), overlapping with DNA
stain, both in Irf8+/+ and Irf8/ DCs, attesting to nuclear
translocation in both DCs. In the majority of cells, there
was residual IRF7-GFP in the cytoplasm after NDV stimu-
lation, suggesting incomplete translocation or rapid
reshuffling. Nuclear translocation of IRF3 was studied by
immunoblot analysis of the cytoplasmic and nuclear frac-
tions prepared before and 1 hr after NDV stimulation
(Figure 4B). There was little cross contamination between
the two fractions, as verified by the selective presence of232 Immunity 27, 228–239, August 2007 ª2007 Elsevier Inc.c-cbl and YY1 in the cytoplasmic and nuclear fractions, re-
spectively. Prior to NDV addition, IRF3 was detected
mostly in the cytoplasmic fraction in Irf8+/+ DCs, although
the nuclear fraction also contained some IRF3. In Irf8/
DCs, IRF3 was almost exclusively in the cytoplasm prior
to infection. After stimulation, the nuclear IRF3 markedly
increased both in Irf8+/+ and Irf8/DCs, along with the re-
duction in the cytoplasm. In agreement with these results,
immunostaining of endogenous IRF3 showed clear nu-
clear translocation after NDV stimulation (Figure 4C).
These data indicate that the TLR signaling cascade func-
tioned normally in Irf8/ DCs to activate IRF3 and IRF7. It
should be noted here that IRF8 resided almost exclusively
in the nucleus and its expression did not change before
and after NDV stimulation for 7 hr, as would have been
expected (Figures 4B and 4D).
Exogenous IRF8 Amplifies IFN Gene Expression
in Fibroblasts
Whereas type I IFNs are produced in many cells including
fibroblasts, IRF8 is expressed only in the cells of hemato-
poietic lineage. It was of interest to test whether ectopic
expression of IRF8 in fibroblasts enhances IFN expres-
sion. To this end, NIH 3T3 fibroblasts were transduced
with a retroviral vector for IRF8, and Ifna and Ifnb transcript
induction was examined after NDV stimulation (Figures 5A
and 5B). Cells transduced with control, empty vector gen-
erated a relatively large first Ifna peak at 2 hr, followed by
a much lower second peak seen between 10 hr and 16 hr.
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Role of IRF8 in Type I IFN Induction in DCsFigure 4. Nuclear Translocation of IRF7 and IRF3 in Irf8/ DCs
(A) Irf8+/+ and Irf8/ DCs were transduced with a vector for IRF7-GFP and stimulated without (control) or with NDV for 1 hr. Cells were fixed and
stained with GFP antibody and counterstained with Hoechst 33342 for DNA. Images are representatives of at least 250 cells inspected for each sam-
ple. Similar results were observed in two to four independent experiments.
(B) Irf8+/+ and Irf8/ DCs were infected with NDV for 1 hr as above, and nuclear and cytoplasmic fractions were tested for indicated proteins by
immunoblot analysis. c-cbl and YY1 were used to monitor the quality of fractionation. Results are representative of two assays.
(C) Irf8+/+ and Irf8/ DCs were stimulated with or without NDV and immunostained with antibody for endogenous IRF3 as in (A).
(D) Irf8+/+ DCs stimulated with NDV for 7 hr, and whole-cell extracts were tested for IRF8 by immunoblot.In contrast, cells transducedwith IRF8generateda second
Ifna peak of much greater magnitude, although themagni-
tude of the first peak was not affected by IRF8. IRF8 also
led to a dramatic amplification of the second peak for Ifnb
transcripts. Ifnb induction in control cells was largely lim-
ited to the first phase, yielding a negligible second peak
under these conditions. We noted that Ifnb transcription
was higher than that of all Ifna transcripts in NIH 3T3 cells,
suggesting a greater significance of this IFN subtype in
fibroblasts. Together, in NIH 3T3 cells, type I IFN induction
followed slower kinetics with a reduced second peak
compared to those in DCs, and IRF8 introduction en-
hanced the second peak without altering the first peak.
To assess domains within IRF8 required for enhancing
IFN induction, a series of IRF8 deletions and mutants
were tested for IFN protein induction in NIH 3T3 cells.
Previous studies have shown that both the DNA binding
domain (DBD, gray in Figure 5C) and the IRF associationdomain in the C-terminal region (IAD, solid) are required
for IRF8’s transcriptional activity. Particularly, lysine (K)
at position 79 and arginine (R) at 289 are essential for ac-
tivity of the DBD and IAD, respectively (Tamura et al.,
2005b; Tsujimura et al., 2003a). In Figure 5D, whereas
full-length IRF8 and 1-390 gave a 6-fold increase in the
total amount of IFNA, other deletions, delN, 1-253, 1-
305, and 1-356, gave only a background amounts of
IFN. The mutants with substitutions in K79 and R289
also failed to enhance IFN production. These data are
consistent with the idea that IRF8 enhances IFN induction
at the point of transcription, not of IFN signaling.
IRF8 Binds to Type I IFN Promoters
Type I IFN transcription requires ordered binding of se-
quence specific factors such as IRF3 and IRF7 as well
as cofactors that affect chromatin, leading to the recruit-
ment of general transcription factors (Agalioti et al.,Immunity 27, 228–239, August 2007 ª2007 Elsevier Inc. 233
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Role of IRF8 in Type I IFN Induction in DCsFigure 5. Amplification of the Second IFN Peak in Fibroblasts after IRF8 Introduction
(A and B) NIH 3T3 cells were transduced with control pMSCV vector or wild-type IRF8 vector and stimulated with NDV for 1 hr, and transcripts for Ifna
and Ifnb were measured as in Figure 1A.
(C) Diagram of IRF8 mutants tested in (D).
(D) NIH 3T3 cells transducedwith indicated IRF8mutants were stimulated with NDV as above and production of IFNAwasmeasured by ELISA. Values
in all panels are the average of three samples. All data are representative of three assays.2000; Maniatis et al., 1998; McWhirter et al., 2004). Ifna
and Ifnb promoters carry IRF binding sites that are vari-
ously called the virus response element (VRE) and PRDI
(Figure S5; Civas et al., 2006; Maniatis et al., 1998; Yang
et al., 2003). To ascertain whether IRF8 participates in
IFN transcription, we performed chromatin immunopre-
cipitation (ChIP) assays for several IFN promoters in
Irf8+/+ and Irf8/ DCs. Figure 6A shows detailed kinetics
of IRF8 binding to the Ifna4 promoter after NDV addition.
Whereas low constitutive IRF8 binding was seen before
stimulation, the binding substantially increased after
NDV stimulation, peaking at 4 hr with a slight decline at
5 and 6 hr. Afterwards, IRF8 binding increased slightly fol-
lowed by a reduction again during the subsequent 11 hr
period, overall showing a mild, oscillating pattern of re-
cruitment, reminiscent of the patterns reported for other
transcription factors (Reid et al., 2003). Specificity of
IRF8 recruitment was substantiated by the lack of binding
by control IgG to the promoter (Figure 6A) as well as by the
lack of IRF8 antibody binding to the unrelated gene hypo-
xanthine guanine phosphoribosyl transferase, HPRT (Fig-
ure S5C). Further confirming specificity of ChIP results,
IRF8 antibody did not bind to the promoter in Irf8/
DCs (Figure 6B). Moreover, IRF8 was recruited to the
Ifna5 and Ifnb promoters as well, with a pattern similar to234 Immunity 27, 228–239, August 2007 ª2007 Elsevier Inc.that for Ifna4, i.e., low constitutive binding prior to NDV
stimulation, followed by increased recruitment after NDV
stimulation (Figures 6B and 6C). We also performed
ChIP assays after TLR signaling and found that IRF8 was
recruited to the Ifna4 promoter after CpG stimulation as
well, supporting the view that IRF8 recruitment to the
promoter is a general event that takes place during IFN in-
duction (Figure S5B).
In Figure 6D, ChIP was performed in Ifnar1/ DCs.
Whereas IRF8 binding to the Ifna4 promoter increased af-
ter NDV stimulation in Ifnar1+/+ DCs, no increase in IRF8
binding was detected in Ifnar1/ DCs. Similar results
were seen for Ifna5 and Ifnb promoter (not shown). These
data indicate that increased IRF8 binding after NDV stim-
ulation depends on IFN feedback signals.
ChIP assays were next performed to examine binding
of IRF7 to the Ifna4 promoter. To this end, we tested
Irf8+/+ and Irf8/ DCs expressing IRF7-Flag (Figure 6E).
IRF7-Flag bound to the promoter to a low degree prior
to NDV addition and the binding increased after NDV stim-
ulation, reached a plateau at 1 or 3 hr and then declined at
6 hr both in Irf8+/+ and Irf8/ DCs. IRF7-Flag binding was
slightly higher in Irf8/ cells than Irf8+/+ DCs, which may
be partly attributed to higher ectopic expression of IRF7
noted in Irf8/ compared to Irf8+/+ cells. ChIP with
Immunity
Role of IRF8 in Type I IFN Induction in DCsFigure 6. Recruitment of IRF8 to the IFN Promoters
(A) Kinetics of IRF8 recruitment to the Ifna4 promoter. Irf8+/+DCs were stimulated with NDV, and ChIP analysis was performed at indicated times with
anti-IRF8 or control IgG. Values in all graphs represent the average of three assays ± SD. Each experiment was reproduced two to three times.
(B) IRF8 ChIP analysis was performed with Irf8+/+ and Irf8/ DCs for the Ifna4 (left) and the Ifna5 promoters (right).
(C) IRF8 ChIP analysis for the Ifnb promoter with Irf8+/+ DCs.
(D) ChIP analysis was performed 3 hr after NDV stimulation for the Ifna4 promoter with Ifnar1+/+ and Ifnar1/ DCs.
(E) Irf8+/+ and Irf8/ DCs were transduced with pMSCV-IRF7-GFP-Flag and stimulated with NDV. ChIP analysis was performed for Ifna4 promoter
with anti-Flag.anti-IRF7 in above cells also showed IRF7 binding both in
Irf8+/+ and Irf8/ cells (Figures S5D and S5E). These re-
sults show that binding of IRF7 to the IFN promoters
does not require IRF8.
IRF8 Supports Sustained RNA Polymerase II
Recruitment to the IFN Promoters
Transcription initiation begins after the assembly of basal
transcription machinery at the promoter (Roeder, 2005;
Sims et al., 2004). RNA polymerase II (RNAPII) is the cen-
tral molecule in the machinery that catalyzes RNA synthe-
sis. To address the mechanism by which IRF8 binding im-
pacts on type I IFN transcription, we performed ChIP
assays for RNAPII. Data in Figure 7A show kinetics of
RNAPII recruitment to the Ifna4 promoter in Irf8+/+ DCs.
RNAPII was not bound before stimulation, but strong
binding was seen at 1 hr after NDV stimulation followed
by a slight reduction at 2 hr. RNAPII recruitment rose again
at 3 hr, after which RNAPII binding remained steady for the
subsequent 6 hr period. In Figures 7B–7D, RNAPII recruit-
ment to the Ifna4, Ifna5, Ifnb promoters was compared be-
tween Irf8+/+ and Irf8/ DCs. RNAPII was recruited 1 hr
after NDV stimulation both in Irf8+/+ and Irf8/ cells on
all promoters. In Irf8+/+ cells, the recruitment continued
for the remaining period. However, in Irf8/ DCs, RNAPII
recruitment rapidly declined after an initial rise; a declinewas seen as early as at 3 hr with a further fall at 6 hr.
Thus, although RNAPII was recruited to the IFN promoters
in the early phase in both Irf8+/+ and Irf8/ DCs, its sub-
sequent recruitment was prematurely attenuated in the
absence of IRF8. These data indicate that IRF8 facilitates
sustained recruitment of RNAPII, most likely responsible
for amplification of IFN transcription in the second phase.
DISCUSSION
This investigation revealed two unique features associ-
ated with type I IFN induction in DCs. First, IFN induction
is composed of two responses, and elicitation of the sec-
ond response, mediated by IFN feedback response, re-
quires IRF8. This conclusion is supported by the observa-
tions that (1) Irf8/ cDCs did not elicit the second IFN
mRNA peak and that (2) ectopic IRF8 conferred a large
second peak upon fibroblasts. Amplification of the second
peak is likely to be a major contributor of copious IFN pro-
duction characteristic to DCs, as shown by the fact that
Irf8/ DCs, although they generated the first response,
produced only a background amount of IFNs. Thus,
IRF8 appears to have a mechanism to augment IFN
gene transcription in DCs in response to both viral and
TLR signals. Our results indicate that IRF8 functions in
a postinduction phase to amplify IFN transcription andImmunity 27, 228–239, August 2007 ª2007 Elsevier Inc. 235
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NDV Stimulation
(A) Kinetics of RNAPII recruitment to the Ifna4 promoter. Irf8+/+ DCs
were stimulated with NDV, and ChIP analysis was performed at indi-
cated timeswith antibody for RNAPII. Values in these graphs represent
the average of three determinations ± SD. Experiments were repro-
duced twice.
(B–D) ChIP for RNAPII was performed with Irf8+/+ and Irf8/ DCs for
the Ifna4 (B), Ifna5 (C), and Ifnb (D) promoters.236 Immunity 27, 228–239, August 2007 ª2007 Elsevier Inc.protein production. The notion that IRF8 acts on a late
phase of transcription is consistent with the previous
reports that IRF8 augments expression of some IFN-
responsive genes with a delayed time course in macro-
phages (Kanno et al., 2005).
The second aspect of DC-specific IFN induction unrav-
eled in this work is that multiple Ifna subtypes are induced
during the first phase in DCs, unlike in non-DCs where the
initial induction is restricted to the Ifnb and Ifna4 subtypes.
Although the molecular basis of this difference is not fully
clear at present, it is possible that the IFN gene cluster as-
sumes an open chromatin configuration in DCs, allowing
IRF3 and IRF7 to have immediate access to multiple Ifna
promoters. Irrespective of themechanism, early activation
of multiple Ifna subtypes may have a large impact on the
overall IFN production in DCs, because it would help pro-
vide a rapid onset and greater elicitation of second re-
sponse. Supporting this view, the onset of the second
peak was seen earlier and its magnitude was markedly
greater in DCs than in NIH 3T3 fibroblasts. In view of
DC-specific mode of gene expression revealed here, the
IFN induction pathways previously outlined for non-DCs
could be modified to accommodate the above character-
istics (Figure S5F).
Our data clearly show that IRF8’s main role is to stimu-
late IFN gene transcription, rather than to act in the up-
stream signaling events. In line with a role in transcription
rather than signaling, IRF8 was not required for nuclear
translocation of IRF3 and IRF7, nor was it required for
establishment of an IFN feedback arm, as evidenced by
induction of IFN-responsive genes in Irf8/ DCs. The in-
volvement of IRF8 in transcription was demonstrated by
the recruitment of IRF8 to the Ifna and Ifnb promoters. In
line with these data, Kawai et al. (2005) identified IRF8
as an activator of Ifnb promoter by screening a spleen
cDNA library. Importantly, IRF8 recruitment was increased
upon NDV addition, peaking at 4 hr well after induction of
the first phase, consistent with its action in the second
phase of transcription. It is clear that increased IRF8 re-
cruitment was dependent on IFN feedback: Ifnar1/
DCs revealed no increase in IRF8 recruitment after NDV.
In these ChIP assays, a low amount of IRF8 appeared to
be bound to the IFN promoters before and soon after
NDV addition, suggesting that some fraction of IRF8 was
recruited to the promoter as a functionally inactive state.
It is of note here that binding of IRF8 (and that of IRF7-
Flag) was not very robust in these experiments, although
reproducibly observed. We attribute the relatively low
binding to the fact that our ChIP assays were performed
with primary DC cultures composed of heterogeneous
cell populations, some of which may not express IFN
genes.
What is the mechanism by which IFN feedback signals
increase IRF8 recruitment? Given that IRF8 expression
remained unchanged before and after NDV stimulation,
it is likely that IFN signals increase the affinity of existing
IRF8 for the promoters, presumably through a post-
translational modification. Phosphorylation of IRF8 may
be a major mechanism of increased binding, in light of
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MAPK families (Darnell, 1996; Platanias, 2005). IFN signals
may also stimulate IRF8 to interact with additional regula-
tory factors not associated before, allowing IRF8 to bind to
the promoter more efficiently. Supporting this view, IRF8
is shown to be under control of tyrosine phosphorylation
and dephosphorylation and to interact with a partner in
an IFN signal-dependent manner (Huang et al., 2006;
Kuwata et al., 2002; Sharf et al., 1997). Ubiquitination of
IRF8, shown to occur through an IFN-inducible E3 ligase,
may also play a role in modulating IRF8’s transcriptional
activity (Kong et al., 2007).
Specific transcription factors, when bound to the regu-
latory element, trigger assembly of many factors at or near
the initiation site, culminating in the recruitment of the
RNAPII complex and synthesis of new RNA chains
(Roeder, 2005; Sims et al., 2004). RNAPII was not present
on the IFN promoters prior to stimulation, but was re-
cruited upon NDV stimulation. Our results are consistent
with signal-dependent recruitment of RNAPII previously
reported for the promoters of inducible proinflammatory
genes (Saccani and Natoli, 2002). Once recruited, RNAPII
continued to occupy the IFN promoters up to 9 hr in Irf8+/+
DCs. However, in Irf8/ cells, RNAPII recruitment fell pre-
maturely after 1 hr in all three promoters. Our data indicate
that IRF8 is equippedwith the capacity to retain RNAPII on
the IFN promoters for an extended period of time. This
capacity is not shared by IRF7, as shown by the fact
that IRF7 was bound to the promoter both in Irf8+/+ and
Irf8/ DCs. It has been shown that activities of RNAPII
are regulated at many steps including those of preinitia-
tion, initiation, elongation, termination, and recycling
(Sims et al., 2004). Given that IFN transcription in DCs
was typified by prolonged RNAPII recruitment, recycling
of RNAPII and transcriptional reinitiation may be an impor-
tant mechanism that constitutes DC-specific IFN tran-
scription. In light of our findings that IRF8 functions during
the second phase of IFN transcription, it is conceivable
that its main role is to support efficient transcriptional rein-
itiation by facilitating repeated recruitment of RNAPII to
the promoters. Although mechanisms controlling RNAPII
recycling are not fully understood, it has been shown
that some DNA-specific transcription factors play a role
in this process (Liu et al., 2001).
In summary, IRF8 plays a key role in amplifying the sec-
ond phase of type I IFN gene transcription in DCs. It helps
prolong RNAP II recruitment to the IFN promoters. To-
gether, IRF8 is a critical contributor of rapid and abundant
type I IFN production typified in DCs, thereby participating
in the establishment of innate immunity.
EXPERIMENTAL PROCEDURES
Mice and Cell Cultures
Irf8/ mice were maintained in the NICHD animal facility. Ifnar1/
mice were obtained from J. Durbin (Ohio State University) through
H. Young (NCI). All animal work conformed to the NICHD animal
care and use committee guidelines. Bone marrow mononuclear cells
were cultured in the presence of Flt3L to generate DCs (Tamura
et al., 2005a; Tsujimura et al., 2003b). DC surface markers were exam-ined by flow cytometry with anti-CD11b, anti-B220, and anti-CD11c
(BD PharMingen), biotin-labeled anti-Siglec-H (Hycult Biotechnology,
Netherlands), and FITC-labeled anti-Ly49Q (MBL International). Data
were analyzed with FlowJo software (Tree Star San Carlos, CA). To
prepare cDC and pDC-enriched DC populations,107 cells were incu-
bated at 4C for 15 min with FITC-conjugated anti-B220 (1:500 dilu-
tion) in 200 ml of PBS containing 0.5% BSA and 2 mM EDTA. Cells
were washed and incubated with anti-FITC microbeads (10 ml) in total
100 ml buffer. Cells were then subjected to magnetic separation with
MACS separation columns (Miltenyi Biotec, Germany). Cells that did
not bind to column were collected as pDC-free cDCs, and the bound
fraction was collected as a pDC-enriched population. For NDV viral
stimulation, 106 DCs were infected with the Heartz stain of NDV at
640 hemagglutination units (Schiavoni et al., 2002) for 1 hr. Similarly,
106 DCs were infected with wild-type MCMV, derived from pSM3fr,
a Bac clone of the Smith strain (Kulesza and Shenk, 2006) at a moi
of 5 for 1 hr. Cells were washed twice and incubated with complete
media and harvested at indicated intervals starting from initial expo-
sure of virus. For stimulation with TLR ligands, DCs were incubated
with 1 mg/ml of CpG 1826 (Lofstrand Labs), 100 mg/ml of polyIC (Amer-
sham Pharmacia), or 100 nM of R848 (Alexis Biochemicals) for indi-
cated periods of time. NIH 3T3 cells were maintained as in Laricchia-
Robbio et al. (2005). 1 3 105 cells in a well of 6-well plate of control
or IRF8-transduced NIH 3T3 cells were infected with NDV at 100
hemaglutination units/ml for 1 hr, and cells were washed twice and
incubated in the media for 24 hr. Supernatants were analyzed for
IFNA production by ELISA (Pestka Biological Laboratories). Total
RNA was extracted with TRIzol reagent (Invitrogen), and cDNA was
prepared with Superscript II enzyme (Invitrogen) according to manu-
facturer’s protocol. For qPCR, amplification of sample cDNA was
monitored with the fluorescent DNA-binding dye SYBR Green (SYBR
Green PCR master kit; Applied Biosystems) in combination with the
ABI Prism 7000 Sequence Detection System (Applied Biosystems),
according to the manufacturer’s instructions. Transcript levels were
normalized by amount of glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) mRNA expression. Primer sequences used for PCR
are listed in Table S2. Semiquantitative RT-PCR was performed with
primer sequence described in Marie et al. (1998).
Retroviral Transduction
pMSCV retroviral vectors for IRF8 and mutants were described
(Tamura et al., 2005a; Tsujimura et al., 2003a). Construction of pMSCV
vector for IRF7-Flag is described along with Table S2. DCs were trans-
ducedwith the viral supernatants prepared in BOSC23 packaging cells
by spinoculation (2400 rpm, 33C, 1 hr) with 4 mg/ml polybrene on day
5 and selected by 2 mg/ml of puromycin for 48 hr (Tamura et al., 2005a).
NIH 3T3 cells were transduced as above and selected with 4 mg/ml
puromycin for 4 days (Laricchia-Robbio et al., 2005).
Immunofluorescent Staining
DCs were placed on cytospin slides and fixed with 4% paraformal-
dehyde, permeabilized with 0.2% Triton X-100 for 5 min, and blocked
by 3% BSA for 1 hr. Cells were incubated with anti-GFP (Roche Ap-
plied Science) diluted at 1:200, or rabbit anti-IRF3 (Zymed) diluted at
1:100 followed by Biotin-conjugated anti-mouse or rabbit IgG (Amer-
sham Biosciences) for 45 min and then incubated with Streptavidin
Alexa-488 (Molecular Probes). Cells were counterstainedwith Hoechst
33342. Stained cells were viewed on a confocal microscope (Leica,
Model TCS, SP2).
Immunoblot Analysis
Nuclear extracts and cytoplasmic fractions were prepared as follows.
Ten million DCs were incubated in 0.3 ml of buffer containing 10 mM
HEPES (pH 7.9), 2.5 mM MgCl2, 10 mM KCl, 0.5% NP-40 with prote-
ase inhibitor cocktail (Roche Applied Science) on ice for 15 min, and
centrifuged. Supernatants were used as cytoplasmic fractions. Nu-
clear pellets were incubated with 20 mM HEPES (pH 7.9), 2.5 mM
MgCl2, 20 mM EDTA, 420 mM KCl, 25% glycerol supplemented withImmunity 27, 228–239, August 2007 ª2007 Elsevier Inc. 237
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natants were collected by centrifugation. Proteins separated on
4%–12% SDS-PAGE were transferred onto PVDF membrane (Milli-
pore) and reacted with indicated antibodies. Secondary detection
was carried out with horseradish peroxidase-conjugated anti-rabbit
IgG or anti-mouse IgG (Amersham Bioscience), followed by chemilu-
minescence development with ECL reagent (Pierce Biotechnology).
ChIP Assays
This assay was performed with the protocol recommended by Upstate
with slight modifications (Tamura et al., 2005a). In brief, 2.5–10 3 106
cells were treated with 1% formaldehyde for 30 min at room tempera-
ture. Cells were lysed in 650 ml of lysis buffer and sonicated on ice with
an XL2007 sonicator (Misonix) to shear DNA into 300 bp–2 kb long
fragments. After centrifugation, 100 ml of supernatants were pre-
cleared with 25% of protein A/G agarose slurry (Santa Cruz Biotech-
nology) supplemented with 200 mg/ml of salmon sperm DNA for 1 hr
at 4C. Chromatin was then incubated with 2 mg of normal goat IgG
or goat anti-IRF8 (C-19, Santa Cruz Biotechnology) overnight with ro-
tation. Normal mouse IgG (2 mg), monoclonal anti-Flag antibody M2
(2 mg, Sigma), Ig control, and rabbit anti-RNAPII (8WG16; Covance)
were used for ChIP assays for IRF7-Flag and RNAPII. This was fol-
lowed by incubation with Protein A/G agarose slurry supplemented
with salmon sperm DNA for additional 1 hr, and precipitated. Precipi-
tates were washed twice with low salt buffer, twice with high salt
buffer, then with a LiCl buffer and finally with Tris-EDTA buffer
(pH 8.0). After elution, complexes were digested with RNase and pro-
teinase K. DNAwas purified by phenol: chloroform, precipitated in eth-
anol, and resuspended in 50 ml of buffer containing 5 mM Tris (pH 8.0).
Five microliters of the final preparations were subjected to qPCR with
primers in Table S2. Input DNA (1%) was used for normalization.
Supplemental Data
Five figures and two tables are available at http://www.immunity.com/
cgi/content/full/27/2/228/DC1/.
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